The U.S. Urea Cycle Disorders (UCD) Treatment Market is estimated to be valued at US$ 510.0 million in 2023 and is expected to exhibit a CAGR of 3.56% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Urea Cycle Disorders (UCD) are a group of rare genetic disorders that affect the body's ability to metabolize ammonia, resulting in its accumulation in the blood. This can lead to ... Read more
